Opiant

$8.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.24%) As of 10:36 AM EST today

Why Robinhood?

You can buy or sell Opiant and other stocks, options, and ETFs commission-free!

About OPNT

Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. It focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. Opiant Pharmaceuticals was founded on June 21, 2005 and is headquartered in Santa Monica, CA. The listed name for OPNT is Opiant Pharmaceuticals, Inc. Common Stock.

CEO
Roger Crystal
Employees
21
Headquarters
Santa Monica, California
Founded
2005
Market Cap
34.79M
Price-Earnings Ratio
Dividend Yield
Average Volume
69.28K
High Today
$8.48
Low Today
$8.17
Open Price
$8.41
Volume
5.04K
52 Week High
$15.68
52 Week Low
$6.79

Collections

OPNT Earnings

-$2.13
-$0.76
$0.60
$1.97
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 3, After Hours

You May Also Like